10-year results in 1577 intermediate/high risk prostate cancer patients treated with external beam RT (EBRT) and hypofractionated high dose rate (HDR) brachytherapy boost

被引：6
|
作者：
Ghilezan, M. [1 ]
Galalae, R. [2 ]
Demanes, J. [3 ]
Schour, L. [3 ]
Gustafson, G.
Nuemberg, N. [2 ]
Wallace, M. [1 ]
Martinez, A. [1 ]
机构：
[1] William Beaumont Hosp, Royal Oak, MI USA
[2] Kile Univ Hosp, Kiel, Germany
[3] Calif Endocurietherapy Ctr, Oakland, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2007.07.151
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S83 / S84
页数：2
相关论文
共 50 条
  • [1] External beam radiotherapy (EBRT) and high dose rate (HDR) brachytherapy for intermediate and high-risk prostate cancer: Whole pelvis or prostate-only EBRT?
    Tharmalingam, Hannah
    Tsang, Yatman
    Choudhury, Ananya
    Hoskin, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [2] External Beam Radiation Therapy (EBRT) and High-Dose-Rate (HDR) Brachytherapy for Intermediate and High-Risk Prostate Cancer: The Impact of EBRT Volume
    Tharmalingam, Hannah
    Tsang, Yatman
    Choudhury, Ananya
    Alonzi, Roberto
    Wylie, James
    Ahmed, Imtiaz
    Henry, Ann
    Heath, Catherine
    Hoskin, Peter J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (03): : 525 - 533
  • [3] Genitourinary (GU) Toxicity in Patients with Intermediate and High-Risk Prostate Cancer Managed with Hypofractionated External Radiation and High Dose Rate (HDR) Brachytherapy Boost
    Goel, A.
    Liu, C. M.
    Kaur, P.
    Wong, M. L.
    Scala, L. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E113 - E113
  • [4] Combined High Dose Rate (HDR) Brachytherapy with External Beam Radiotherapy (EBRT) Results in a High Rate of Biochemical Disease Free Survival (DFS) in Localised Intermediate and High Risk Prostate Cancer Patients
    Joseph, N.
    Taylor, C.
    Choudhury, A.
    Elliott, T.
    Logue, J.
    Wylie, J.
    [J]. CLINICAL ONCOLOGY, 2016, 28 (05) : E13 - E13
  • [5] Improving the results of intermediate risk prostate cancer treated with high dose rate (HDR) brachytherpy and hypofractionated external beam radiation therpy author
    Cury, F.
    Duclos, M.
    Aprikian, A.
    Shenouda, G.
    Faria, S.
    David, M.
    Patrocinio, H.
    Evans, M.
    Souhami, L.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S15 - S15
  • [6] Long-term chronic toxicity profile of a dose escalating hypofractionated pelvic external beam radiation therapy (EBRT) with a high dose rate Brachytherapy (HDR-BT) boost for intermediate and high risk prostate cancer
    Marvin, K.
    Wallace, M.
    Ghilezan, M.
    Gustafson, G.
    Kestin, L.
    Sebastian, E.
    Martinez, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S95 - S96
  • [7] A comprehensive toxicity analysis of 1232 prostate cancer patients treated with pelvic external beam radiotherapy (EBRT) with high dose rate (HDR) brachytherapy boost, adaptive EBRT (ART), or brachytherapy alone (BT)
    Ghilezan, M.
    Kestin, L.
    Gustafson, G.
    Brabbins, D.
    Vicini, F.
    Chen, P.
    Yan, D.
    Martinez, A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S59 - S60
  • [8] High-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for intermediate/high risk prostate cancer
    Ishikawa, H.
    Sakurai, H.
    Akimoto, T.
    Ebara, T.
    Okamoto, M.
    Noda, S.
    Katoh, H.
    Yoshida, D.
    Ito, K.
    Nakano, T.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S307 - S307
  • [9] Results of high dose rate (HDR) brachytherapy boost for prostate cancer
    Kelly, D
    Flynn, J
    Brookover, W
    [J]. RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S18 - S18
  • [10] A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients
    Joseph, Nuradh
    Taylor, Cathy
    O'Hara, Catherine
    Choudhury, Ananya
    Elliott, Tony
    Logue, John
    Wylie, James
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 121 (02) : 299 - 303
12345